Left untreated, hepatitis B can silently damage the liver over decades, potentially leading to cirrhosis, liver cancer, and liver failure. The severity depends largely on whether the infection becomes chronic, which itself depends on the age at which a person was infected. Adults who contract hepatitis B have less than a 5% chance of developing a chronic infection, while infants infected at birth progress to chronic hepatitis about 95% of the time. It’s the chronic form that causes the most serious long-term harm.
Why Chronic Hepatitis B Is Silent for So Long
One of the most dangerous aspects of untreated hepatitis B is that it can cause progressive liver damage without any noticeable symptoms for years or even decades. After infection, many people enter what’s called an immune tolerance phase, where the virus replicates at high levels but the body doesn’t mount a strong inflammatory response against it. During this phase, liver enzymes stay normal, there’s little detectable liver damage on biopsy, and the person feels fine.
For people infected at birth or in early childhood, this quiet phase can last 10 to 30 years before the immune system finally begins attacking virus-infected liver cells. When that immune response kicks in, it causes inflammation, and repeated cycles of inflammation and healing gradually replace healthy liver tissue with scar tissue. By the time symptoms like fatigue, abdominal pain, or jaundice appear, significant damage may already be done.
Progression to Cirrhosis
Cirrhosis is the result of years of ongoing liver scarring. Among people with chronic hepatitis B, cirrhosis develops at a rate of roughly 2.8 per 100 people per year. Over a lifetime, an estimated 15% to 40% of people with chronic infection will develop cirrhosis or liver cancer.
In its early stages, cirrhosis is called “compensated,” meaning the liver still functions well enough to keep the body running. Five-year survival at this stage is relatively high. But once cirrhosis progresses to “decompensated” liver disease, where the liver can no longer perform its essential jobs, serious complications set in: fluid buildup in the abdomen, internal bleeding from swollen veins in the esophagus, confusion caused by toxins the liver can no longer filter, and eventually liver failure. A study of 379 patients with chronic hepatitis B found that five-year survival dropped to 55% for those with active hepatitis and cirrhosis, compared to 97% for those with milder, persistent inflammation.
Liver Cancer Risk
Hepatitis B is one of the leading causes of hepatocellular carcinoma, the most common type of liver cancer. What makes this particularly concerning is that liver cancer can develop even in people who haven’t yet progressed to full cirrhosis, though the risk is much higher once cirrhosis is present.
A large meta-analysis covering nearly 350,000 patients quantified the annual liver cancer rates based on disease stage. For people with chronic hepatitis but no cirrhosis, the incidence was roughly 0.1 to 0.5 per 100 people per year, depending on geographic region. Once compensated cirrhosis developed, that rate jumped dramatically to 2 to 3.4 per 100 people per year. Age was a strong independent risk factor: the older a person gets with untreated infection, the higher their cancer risk climbs. Heavy alcohol use (60 grams or more per day) and high levels of circulating virus also significantly increased the risk.
Damage Beyond the Liver
Untreated hepatitis B doesn’t only affect the liver. The virus triggers immune responses that can deposit clusters of antibodies and viral proteins in blood vessels, kidneys, and other tissues, causing inflammation far from the liver itself. These complications include:
- Kidney disease: Several forms of kidney inflammation can develop, particularly in people infected during infancy or early childhood. Immune complexes lodge in the kidney’s filtering units, gradually impairing function.
- Blood vessel inflammation (polyarteritis nodosa): This affects 1% to 5% of people with hepatitis B and can cause joint pain, rash, fever, abdominal pain, nerve damage, high blood pressure, and kidney failure. It can appear within the first six months of infection.
- Other systemic effects: Chronic infection has been linked to joint inflammation, skin disorders, neurological problems, and blood abnormalities.
These complications are driven by the immune system’s ongoing reaction to the virus rather than by direct viral damage, which is why they can occur even when liver disease appears mild.
The Risk of Spreading to Others
Leaving hepatitis B untreated also means living with a higher chance of transmitting the virus, especially from mother to child during birth. The risk is directly tied to how much virus is circulating in the blood. Mothers with very high viral loads have a pooled transmission rate of about 14.4%, compared to roughly 2.8% for those with lower levels. Each tenfold increase in viral load raises the odds of transmission by about 40%. Without treatment to suppress the virus, the risk of passing the infection to a newborn, who then faces a 95% chance of becoming a chronic carrier, remains substantial.
Sexual and household transmission also increases with higher viral loads. Hepatitis B is 50 to 100 times more infectious than HIV, and untreated individuals with active viral replication pose the greatest transmission risk to close contacts.
The Global Scale of the Problem
Untreated hepatitis B is the second leading infectious cause of death worldwide, on par with tuberculosis. In 2022, viral hepatitis killed an estimated 1.3 million people globally, up from 1.1 million in 2019. Hepatitis B accounted for 83% of those deaths. That translates to roughly 3,500 people dying every day from hepatitis B and C combined, the vast majority from complications that developed over years of untreated infection.
Most of these deaths are preventable. Antiviral treatment can suppress the virus to undetectable levels, halt or even reverse liver scarring, dramatically reduce cancer risk, and cut transmission rates. The challenge is that because the virus causes no symptoms for so long, many people don’t know they’re infected until liver damage is advanced. Screening is the critical first step, particularly for people born in regions where hepatitis B is common, those with a family history of the infection, and anyone who has never been vaccinated.